As our study demonstrates relevance of TUBB4B in Oral cancer stem cell niche, we believe targeting TUBB4B using specific small molecule inhibitors could be a potential aid in clearing the CSC population by creating an imbalance in the CSC niche. The gene discussed is TUBB4B; the disease is lip and oral cavity carcinoma.